Brief: Santhera Pharmaceuticals Holding AG Proposes A Reverse Share Split In Ratio 10:1
June 6 (Reuters) - Santhera Pharmaceuticals Holding AG
SANN.S :
* PROPOSES A REVERSE SHARE SPLIT IN RATIO 10:1
Source text for Eikon: ID:nGNXbjGZJP
Further company coverage: SANN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Santhera Pharmaceuticals Holding AG
See all newsSwitzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -6.562 Million
Brief: Santhera Says NXERA Plans To Submit South Korea Marketing Authorization Application 2026
Brief: Santhera Gets Positive CHMP Opinion To Expand Agamree (Vamorolone) Use
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -35.444 Million